Products

Cleanroom Products

Akron is a leader in providing cleanroom products and in managing mycoplasma infection, offering the CleanSolutions and MycoSolutions range of products.

 

Mycoplasma infection can eradicate critical cell lines. Akron CleanSolutionsTM and MycoSolutionsTM products are at the forefront in preventing contamination and detecting and eliminating mycoplasma infection.

CleanSolutionsTM is available as a hand sanitizer and as disinfecting wipes, and as a disinfecting spray for incubators, water baths, and laboratory work surfaces. The MycoSolutionsTM  PCR kit offers a quick, cost-effective, accurate way to monitor for mycoplasma infection. If infection is detected, use MycoSolutionsTM 1, 2, and 3.

In addition to regular cleaning, we strongly recommend testing new cell lines entering the tissue culture facility. We further recommend monitoring for existing mycoplasma infection by testing cells in culture at least once a month.

Don’t leave your laboratory unprotected. CleanSolutionsTM can help keep it free of environmental contaminants, and MycoSolutionsTM can help protect against mycoplasma infection.

SHARE

CATEGORY

Category Filters

Sub cat: MycoSolutions

4 Products Found


Results per page
Permalink to these results

Name Description
Mycosolutions™ - Real-Time PCR Mycoplasma Detection Kit
Order Now Akron Biotech’s MycoSolutions™ Real-Time PCR Mycoplasma Detection Kit is a best-in-class product for the detection of contaminated cultures.
More Information »
View Description Catalog no. Size Price Quantity
RT-PCR Mycoplasma Detection Kit AK9752-0010 10 rxn $150.00
RT-PCR Mycoplasma Detection Kit AK9752-0020 20 rxn $280.00
MycoSolutions™ 1&2 - Mycoplasma Treatment
Order Now MycoSolutions™ 1&2 consist of semi-synthetically derived antibiotics which prevent, treat, and control contamination of cell lines by Mycoplasma species. MycoSolutions™ 2 offers treatment options when used sequentially and in combination with MycoSolutions™ 1 to take advantage of antibiotic synergism. This combination of antibiotics has been shown to be effective in the elimination of mycoplasma that account for 90% of the contamination found in cell cultures.
More Information »
View Description Catalog no. Size Price Quantity
MycoSolutions 1&2 AK8360-0010 10ml $95.00
MycoSolutions 1&2 AK8360-0020 20ml $155.00
MycoSolutions 1&2 AK8360-0100 100ml $545.00
MycoSolutions™ 3 - Mycoplasma Treatment
Order Now MycoSolutions™- 3 is a solution based on the antibiotic Ciprofloxacin. This antibiotic belongs to the Fluoroquinolone group that inhibits synthesis of the enzyme DNA gyrase, which is responsible for supercoiling on bacterial DNA. Many mycoplasma species have been found to be sensitive to MycoSolutions- 3, including A.laidlawii, M.orale, M.hyorhinis, M.fermentans, and M.arginini. These species account for 90% of the contamination found in cell cultures.
More Information »
View Description Catalog no. Size Price Quantity
MycoSolutions 3 AK5240-0010 10ml $38.00
MycoSolutions 3 AK5240-0020 20ml $64.00
MycoSolutions 3 AK5240-0100 100ml $230.00
MycoSolutions™- PCR Mycoplasma Detection Kit
Order Now The PCR Mycoplasma Detection Kit employs a nucleic acid amplification test on the basis of a polymerase chain reaction (PCR). The PCR method allows a fast and highly sensitive detection of mycoplasma contamination in biological samples. The contained primers are specific to a segment of the 16S rRNA region of the mycoplasma genome. The amplified PCR product has a size of approximately 270bp and can directly be made visible in an agarose gel. The selected template is highly conserved within the s
More Information »
View Description Catalog no. Size Price Quantity
PCR Mycoplasma Detection Kit AK3744-0020 20 tests $320.00
PCR Mycoplasma Detection Kit AK3744-0010 10 tests $210.00
Akron Biotech Products
Growth factors, cytokines, cell culture, stem cells, primary cells, sera, tissue, extracts, plasma,regenerative medicine, 3D scaffolds
As a global supplier, Akron manufactures and distributes components of and raw materials for cell therapy discovery, preclinical and clinical development through to commercialization.